GlassScriptPhysician profile
Regina M Hampton
NPI 1356338230
$2,979.58
in general payments reported to CMS, 2019-2025
29 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $367 · 2021: $165 · 2022: $33.13 · 2023: $308 · 2024: $712 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543 · Travel and Lodging: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.15 |
| Travel and Lodging | $622.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Isono Health, INC. | $886.76 | 2025 | Atusa |
| Vector Surgical, LLC | $450.00 | 2020-2021 | |
| Baxter Healthcare | $304.72 | 2023-2024 | Perclot |
| Endomagnetics LTD | $201.02 | 2024 | Magtrace, Magseed |
| Molli Surgical (US) INC | $188.41 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $110.73 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Stryker Corporation | $97.91 | 2024 | Photonblade, Stryker |
| Astrazeneca Pharmaceuticals LP | $64.15 | 2025 | Lynparza, Calquence |
| Genentech USA, INC. | $58.51 | 2019 | |
| Myriad Genetic Laboratories, INC. | $56.79 | 2022-2023 | Bracanalysis Cdx |
| Hologic Sales and Service, LLC | $53.93 | 2023-2024 | Localizer |
| Janssen Biotech, INC. | $52.27 | 2019-2020 | |
| Medtronic, INC. | $51.52 | 2024-2025 | Ligasure, V-Loc 180 |
| Eisai INC. | $43.10 | 2019 | |
| Celgene Corporation | $39.10 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $33.44 | 2019-2020 | |
| Integra Lifesciences Corporation | $32.37 | 2023 | Durasorb Monofilament Mesh |
| Tempus Ai, INC | $29.42 | 2025 | Xt Cdx |
| Impedimed, INC. | $27.63 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $26.92 | 2025 | Onivyde |
| Foundation Medicine, INC. | $26.25 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $24.60 | 2025 | Exparel |
| Cashflow Solutions, LLC | $22.41 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kyowa Kirin, INC. | $19.44 | 2025 | |
| Incyte Corporation | $17.37 | 2019 | |
| Puma Biotechnology, INC. | $16.16 | 2020 | |
| Kci USA, INC. | $15.95 | 2019 | |
| Smith+Nephew, INC. | $15.10 | 2021 | |
| Tactile Systems Technology INC | $13.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.